An Observational Study of Patients With Malignant Lymphomas Treated With MabThera® SC in Everyday Clinical Practice
CompletedOBSERVATIONAL
Enrollment
688
Participants
Timeline
Start Date
July 8, 2014
Primary Completion Date
July 22, 2019
Study Completion Date
July 22, 2019
Conditions
Lymphoma, B-Cell, Lymphoma, Follicular
Trial Locations (1)
45122
Universitätsklinikum Essen; Klinik für Hämatologie, Essen
All Listed Sponsors
lead
Hoffmann-La Roche
INDUSTRY
NCT02240316 - An Observational Study of Patients With Malignant Lymphomas Treated With MabThera® SC in Everyday Clinical Practice | Biotech Hunter | Biotech Hunter